322 related articles for article (PubMed ID: 16436655)
1. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
4. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.
Wang L; Piguet AC; Schmidt K; Tordjmann T; Dufour JF
Hepatology; 2005 Jun; 41(6):1241-51. PubMed ID: 15861431
[TBL] [Abstract][Full Text] [Related]
5. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat.
Úriz M; Sáez E; Prieto J; Medina JF; Banales JM
PLoS One; 2011; 6(12):e28717. PubMed ID: 22194894
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.
Beuers U; Nathanson MH; Isales CM; Boyer JL
J Clin Invest; 1993 Dec; 92(6):2984-93. PubMed ID: 8254052
[TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
[TBL] [Abstract][Full Text] [Related]
12. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
13. Taurine zinc solid dispersions enhance bile-incubated L02 cell viability and improve liver function by inhibiting ERK2 and JNK phosphorylation during cholestasis.
Wang Y; Mei X; Yuan J; Lai X; Xu D
Toxicology; 2016 Jul; 366-367():10-9. PubMed ID: 27501764
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.
Barone M; Maiorano E; Ladisa R; Pece A; Berloco P; Strazzabosco M; Caruso ML; Valentini AM; Ierardi E; Di Leo A; Francavilla A
Virchows Arch; 2004 Jun; 444(6):554-60. PubMed ID: 15071740
[TBL] [Abstract][Full Text] [Related]
15. Permeability of the rat biliary tree to ursodeoxycholic acid.
Farges O; Corbic M; Dumont M; Maurice M; Erlinger S
Am J Physiol; 1989 Apr; 256(4 Pt 1):G653-60. PubMed ID: 2705526
[TBL] [Abstract][Full Text] [Related]
16. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
17. Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver.
Nakai T; Katagiri K; Hoshino M; Hayakawa T; Ohiwa T
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):613-7. PubMed ID: 1361125
[TBL] [Abstract][Full Text] [Related]
18. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
Baiocchi L; Tisone G; Russo MA; Longhi C; Palmieri G; Volpe A; Almerighi C; Telesca C; Carbone M; Toti L; De Leonardis F; Angelico M
Transpl Int; 2008 Aug; 21(8):792-800. PubMed ID: 18435680
[TBL] [Abstract][Full Text] [Related]
19. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism.
Marucci L; Alpini G; Glaser SS; Alvaro D; Benedetti A; Francis H; Phinizy JL; Marzioni M; Mauldin J; Venter J; Baumann B; Ugili L; LeSage G
Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G290-301. PubMed ID: 12388182
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
